SGD Pharma will launch My Sterinity Nasal at The DCAT (Drug, Chemical & Associated Technologies Association) Week 2026

We’re thrilled to showcase My Sterinity Nasal, which will be developed with Prince Sterilization Services.

This platform combines SGD Pharma’s Type I U-save vials with Prince’s RTU sterilization expertise, offering validated, ready-to-use packaging for high-value nasal therapies.

  • Controlled purity
  • Biologically inert Type I glass
  • Compatible with preservative-free nasal pumps
  • Double-bagged RTU formats

Produced at our plant of Saint Quentin La Motte (France), our Type I center of excellence, with a regional US supply chain, My Sterinity Nasal solution ensures stability, safety, and efficacy for sensitive nasal drug delivery, from acute to chronic therapies.